ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N05AX08 | B | Risperidone - 4mg | 4071 | 194143/05 | RISPERDAL | 4mg | 20 | Tablet | Oral | Mersaco | Janssen Cilag SpA | Italy | 498,566 L.L | 23.08 | A1 | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N05AX08 | B | Risperidone - 4mg | 10523 | 17220/1 | RISPERDAL | 4mg | 20 | Tablet | Oral | Mersaco | Janssen Cilag SpA | Italy | 498,566 L.L | 23.08 | A1 | Janssen Cilag NV | Belgium | 2/5/2024 | 0 |
N05AX08 | G | Risperidone - 4mg | 4399 | 973306/01 | DEPIA | 4mg | 20 | Tablet, scored | Oral | Pharmapro | Mediphar Laboratories | Lebanon | 499,142 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
N05AX08 | G | Risperidone - 4mg | 5523 | 221867/08 | PMS-RISPERIDONE | 4mg | 60 | Tablet | Oral | UPO S.A.L. | Pharmascience Inc | Canada | 1,276,650 L.L | 23.08 | A2 | Pharmascience Inc | Canada | 2/5/2024 | 0 |
N05AX08 | G | Risperidone - 4mg | 5040 | 194102/05 | RESPAL 4 | 4mg | 20 | Caplet, film coated | Oral | The Lebanese Pharmacists SAL | Joswe Medical (Jordan Sweden Medical and Sterilization Co) | Jordan | 1,224,241 L.L | 23.08 | A2 | 2/5/2024 | 0 | ||
N05AX08 | G | Risperidone - 4mg | 11076 | 56621/1 | RISPERIDONE BIOGARAN | 4mg | 30 | Tablet, coated, scored | Oral | Commercial and Trading Ressources SAL (CTR) | Egis Pharmaceuticals PLC | Hungary | 1,105,982 L.L | 23.08 | A2 | Laboratoires Biogaran | France | 2/5/2024 | 0 |